PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35386046-4	2022	RESULTS: Compared with remdesivir, HCQ/CQ was associated with increased reporting of SCAEs (reporting odds ratio (ROR) 2.1; 95% confidence interval (CI) 1.8-2.5), torsade de pointes (TdP)/QTc prolongation (ROR 35.4; 95% CI 19.4-64.5), and ventricular arrhythmia (ROR 2.5; 95% CI 1.6-3.9); similar results were found in comparison with other therapeutic alternatives.	Hydroxychloroquine	35-38	receptor tyrosine kinase like orphan receptor 2	Homo sapiens	114-117	
35386046-4	2022	RESULTS: Compared with remdesivir, HCQ/CQ was associated with increased reporting of SCAEs (reporting odds ratio (ROR) 2.1; 95% confidence interval (CI) 1.8-2.5), torsade de pointes (TdP)/QTc prolongation (ROR 35.4; 95% CI 19.4-64.5), and ventricular arrhythmia (ROR 2.5; 95% CI 1.6-3.9); similar results were found in comparison with other therapeutic alternatives.	Hydroxychloroquine	35-38	receptor tyrosine kinase like orphan receptor 2	Homo sapiens	206-209	
35386046-4	2022	RESULTS: Compared with remdesivir, HCQ/CQ was associated with increased reporting of SCAEs (reporting odds ratio (ROR) 2.1; 95% confidence interval (CI) 1.8-2.5), torsade de pointes (TdP)/QTc prolongation (ROR 35.4; 95% CI 19.4-64.5), and ventricular arrhythmia (ROR 2.5; 95% CI 1.6-3.9); similar results were found in comparison with other therapeutic alternatives.	Hydroxychloroquine	35-38	receptor tyrosine kinase like orphan receptor 2	Homo sapiens	263-268